Home > Insider Trading > Filing (0001209191-14-046101)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1131324	Genomic Health Inc	GHDX	Services-Medical Laboratories (8071)	770552594

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1337334	Steven Shak	301 Penobscot Drive Redwood City CA 94063	Evp Of R&D	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-07-01	7,000	$2.88	319,298	No	4	M	Direct
Common Stock	Disposition	2014-07-01	7,000	$27.00	312,298	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2014-07-01	7,000	$0.00	7,000	$2.88

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
13,348		2014-12-02	No	4	M	Direct

Footnotes

The sale of common stock represents a trade pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on September 9, 2013 that was scheduled to occur on June 13, 2014 but was not executed until July 1, 2014 due to an error by the broker.
Represents the price received by the reporting person, and is equal to the volume weighted average price of the Issuer's common stock on June 13, 2014, the scheduled trade date under the reporting person's Rule 10b5-1 sales plan.
Includes an aggregate of 10,594 shares of common stock issuable pursuant to previously reported restricted stock unit awards that have not vested.
The option became exercisable as to 25% of the shares on December 2, 2005, and becomes exercisable as to 1/48th of the shares each full month thereafter.